Entrez Gene

General information | Expression | Regulation | Mutation | Interaction

Basic Information
Gene ID	10301
Name	DLEU1
Synonymous	BCMS\|DLB1\|DLEU2\|LEU1\|LEU2\|LINC00021\|NCRNA00021\|XTP6;deleted in lymphocytic leukemia 1 (non-protein coding);DLEU1;deleted in lymphocytic leukemia 1 (non-protein coding)
Definition	-
Position	13q14.3
Gene type	miscRNA
Source	Count: 3; TAG,Generif,UniProt
Sentence	Abstract
We conclude that the Leu1 and Leu2 genes are strong candidates as tumor suppressor gene(s) involved in B-CLL leukemogenesis.	Previous studies have indicated the presence of a putative tumor suppressor gene on chromosome 13q14, commonly deleted in patients with B-cell chronic lymphocytic leukemia (B-CLL). We have previously defined a minimally deleted region of 130 kb centromeric to the marker D13S272, and constructed a PAC and cosmid contig encompassing this area. In the present study we have made a detailed restriction and transcriptional map of the region of interest. Using these tools we have screened a panel of 206 primary CLL clones and three cell lines. In five CLL cases we found limited deletions defining the region of interest to an area of no more than 10 kb. Two adjacent genes, termed Leu1 and Leu2 (leukemia-associated gene 1 and 2), were mapped to the minimally deleted region, with several patients showing deletion borders within these genes. The Leu1 and Leu2 genes show little homology to previously published genes at the nucleotide and expected translated amino acid sequence level. mutational analysis of the Leu1 and 2 genes in 170 CLL samples revealed no small intragenic mutations or point mutations. However, in all cases of 13q14 loss examined, the first exon of both genes, which are only 300 bp apart, were deleted. We conclude that the Leu1 and Leu2 genes are strong candidates as tumor suppressor gene(s) involved in B-CLL leukemogenesis.